Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases

摘要

Compositions and methods comprising “lymphotoxin-&bgr; receptor blocking agents” which block lymphotoxin-&bgr; receptor signaling and are useful for altering immunological diseases, and particularly antibody mediated immune responses.